Will Long Acting Insulin Analogs Influence the Use of Insulin Pump Therapy in Type 1 Diabetes?

By  

Current Diabetes Reviews, Vol. 1, Iss. 1, 2005-01 ,pp. : 23-26

Bentham Science Publishers

Access to resources Recommend Favorite

Albiglutide: clinical overview of a long-acting GLP-1 receptor agonist in the treatment of Type 2 diabetes

By Setji Tracy   Feinglos Mark  

Expert Review of Endocrinology and Metabolism, Vol. 8, Iss. 3, 2013-05 ,pp. : 229-238

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness and Safety of Dabigatran and Warfarin in Real‐World US Patients With Non‐Valvular Atrial Fibrillation: A Retrospective Cohort Study

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 4, 2015-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of switching from NPH insulin to insulin glargine in patients with type 2 diabetes: the retrospective, observational LAUREL study in Italy

By Bellia Alfonso   Babini Anna   Marchetto Paolo   Arsenio Leone   Lauro Davide   Lauro Renato  

Acta Diabetologica, Vol. 51, Iss. 2, 2014-04 ,pp. : 269-275

Springer Publishing Company

Access to resources Recommend Favorite

Risk factor management in stable, insulin-treated patients with Type 2 diabetes - The Diabetes Outcomes in Veterans Study

By Murata G.H.   Shah J.H.   Wendel C.S.   Hoffman R.M.   Adam K.D.   Bokhari S.U.   Solvas P.A.   Duckworth W.C.  

Journal of Diabetes and its Complications, Vol. 17, Iss. 4, 2003-07 ,pp. : 186-191

Elsevier

Access to resources Recommend Favorite